Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M360Revenue (TTM) $M4.2Net Margin (%)2,359Altman Z-Score12.8
Enterprise Value $M340EPS (TTM) $1.0Operating Margin %-1,096.6Piotroski F-Score4
P/E(ttm)3.4Beneish M-Score-1.0Pre-tax Margin (%)2,210Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %32.5Quick Ratio3.3Cash flow > EarningsN
Price/Sales77.45-y EBITDA Growth Rate %10.1Current Ratio3.3Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)73.5Higher Current Ratio y-yY
Dividend Yield %--PEG0.3ROE % (ttm)95.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M111ROIC % (ttm)-47.1Gross Margin Increase y-yY

Gurus Latest Trades with BTX

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

BTX is held by these investors:



BTX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ANDREWS DEBORAH JDirector 2017-05-16Buy2,000$3.211.25view
BROADWOOD PARTNERS, L.P.Director, 10% Owner 2017-02-15Buy2,222,222$2.720.37view
BROADWOOD PARTNERS LPDirector, 10% Owner 2016-06-21Buy2,732,636$2.3935.98view
BROADWOOD PARTNERS LPDirector, 10% Owner 2016-01-20Buy300,000$2.3538.3view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2016-01-20Sell300,000$2.3538.3view
FARRELL STEPHEN CDirector 2015-11-06Buy50,000$3.83-15.14view
Russell Angus C.Director 2015-11-06Buy50,000$3.83-15.14view
KINGSLEY ALFRED DSee Remarks, 10% Owner 2015-11-06Sell100,000$3.83-15.14view
ANDREWS DEBORAH JDirector 2015-08-26Buy2,000$2.8215.25view
Cartt Stephen LaHueDirector 2015-08-18Buy75,000$2.816.07view

Quarterly/Annual Reports about BTX:

News about BTX:

Articles On GuruFocus.com
Weekly CFO Buys Highlight: BTX, CWST, BKSC, STAG Jun 27 2011 
Weekly CEO Buys Highlight: PCYC, HLX, FSC, CREG, BTX Jun 25 2011 

More From Other Websites
BioTime, Inc. breached its 200 day moving average in a Bullish Manner : BTX-US : May 25, 2017 May 25 2017
BioTime Co-CEO Dr. Michael West to Deliver Presentation as Part of Biotech Panel at Mauldin... May 23 2017
BioTime to Present at 16th National Life Sciences and Biotechnology Week (MIXiii BIOMED) May 23 2017
Endocyte (ECYT) Reports Narrower-than-Expected Loss in Q1 May 11 2017
BioTime Presents Retinal Restoration Data at ARVO May 11 2017
BioTime posts 1Q profit May 10 2017
BioTime, Inc. Reports First Quarter Results and Recent Corporate Accomplishments May 10 2017
Valeant (VRX) Q1 Earnings & Revenues Miss, View Raised May 10 2017
Prothena (PRTA) Q1 Loss Narrower than Expected, Updates View May 10 2017
BioTime Announces New Positive Data from OpRegen® Trial in Dry-AMD May 09 2017
BioTime, Inc. : Undervalued relative to peers, but don’t ignore the other factors May 08 2017
BioTime Co-CEO Dr. Michael D. West to Present at World Advanced Therapies & Regenerative Medicine... May 08 2017
BioTime, Inc. is trading below its 50 day moving average : BTX-US : May 5, 2017 May 05 2017
BioTime, Inc. breached its 50 day moving average in a Bearish Manner : BTX-US : May 2, 2017 May 02 2017
BioTime, Inc. to Announce First Quarter 2017 Results on May 10, 2017 Apr 26 2017
BioTime to Present Additional Data at Upcoming ARVO Apr 24 2017
BioTime, Inc. is trading below its 50 day moving average : BTX-US : April 21, 2017 Apr 21 2017
BioTime, Inc. – Value Analysis (NYSE MKT:BTX) : April 20, 2017 Apr 20 2017
BioTime, Inc. breached its 50 day moving average in a Bearish Manner : BTX-US : April 19, 2017 Apr 19 2017
ETFs with exposure to BioTime, Inc. : April 13, 2017 Apr 13 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)